0

Purchase Short-Term Access

Significant Differential Effects of Alendronate, Estrogen, or Combination Therapy on the Rate of Bone Loss after Discontinuation of Treatment of Postmenopausal Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Susan L. Greenspan, MD; Ronald D. Emkey, MD; Henry G. Bone, MD; Stuart R. Weiss, MD; Norman H. Bell, MD; Robert W. Downs, MD; Clark McKeever, MD; Sam S. Miller, MD; Michael Davidson, MD; Michael A. Bolognese, MD, PC; Anthony L. Mulloy, PhD, DO; Norman Heyden, RPh, MS; Mei Wu, MS; Amarjot Kaur, PhD; Antonio Lombardi, MD
Annals of Internal Medicine 2002;137:875-883. doi:10.7326/0003-4819-137-11-200212030-00008

Purchase Online access to this article for 24 hours
Buy Now
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)